Synedica NAD+ & B12 Injection Pen

Synedica NAD+ & B12 Injection Pen is a dual-compound research formulation designed to support cellular energy metabolism, mitochondrial activity, and metabolic efficiency studies. This pen-based system combines nicotinamide adenine dinucleotide (NAD+) with vitamin B12 to deliver a synergistic approach for advanced laboratory research.

NAD+ plays a central role in cellular energy transfer and redox reactions, while vitamin B12 contributes to neurological and metabolic pathways. Together, these compounds are widely studied in longevity, energy optimisation, and cellular-performance research models.

Key Features

• Combined NAD+ and B12 formulation

• Pen-based delivery for controlled dosing

• Designed for cellular and metabolic research

• Consistent concentration and stability

• Manufactured under laboratory-grade standards

How It Works

This formulation supports cellular metabolism by contributing to mitochondrial energy production and enzymatic activity. NAD+ functions as a key coenzyme in ATP generation, while B12 supports metabolic and neurological pathways involved in energy utilisation.

Research Applications

Synedica NAD+ & B12 Injection Pen  Commonly selected for:

• Cellular energy and mitochondrial research

• Longevity and metabolic efficiency studies

• Fatigue and energy-pathway investigations

• Combination-compound research protocols

Pen-Based Delivery Advantage

The injection pen format improves handling consistency, reduces preparation variability, and supports repeatable dosing across extended research timelines.

Storage & Quality

Store refrigerated, protect from light, and do not freeze. Intended strictly for research use only.